About TUDCA

Naturally occurring bile acid used as a supplement to support liver health, protect cells from stress, and improve bile flow.

Effectiveness Scores

Liver Health: 8.0/10 (moderate evidence) —
TUDCA helps protect liver cells by improving how bile is handled in the liver. It replaces more harmful bile acids with gentler ones, which reduces the damage that can be caused when it builds up. In certain liver diseases, bile cannot flow properly and begins to accumulate inside the liver. This buildup can damage liver cells and lead to inflammation, fibrosis, and eventually liver failure. By reducing bile toxicity and protecting liver cells, TUDCA may help slow this damage and improve liver function.
Why this rating: This is one of the areas with the strongest evidence for TUDCA. Multiple human trials show meaningful improvements in liver markers and cholestatic disease outcomes. The rating is not higher because most studies involve people with existing liver disease rather than healthy populations. Some trials are also relatively small, and long-term data beyond about a year is limited.
Digestive Health: 6.0/10 (moderate evidence) —
TUDCA is a bile acid that increases bile flow and improves bile solubility, both of which are central to fat digestion and nutrient absorption. Poor bile function can lead to digestive discomfort, nutrient deficiencies, and gallstone formation. Animal studies also suggest it may support the intestinal barrier and help maintain gut integrity.
Why this rating: The biological mechanism is well understood, and clinical use for gallstones is validated. However, the connection between treating gallstones and improving general digestion in healthy individuals lacks human trial evidence. Current claims rest on pharmacology and anecdotal experience, placing confidence at moderate rather than high.
Insulin Sensitivity and Glucose Metabolism: 6.0/10 (moderate evidence) —
TUDCA may help the body respond to insulin more effectively. It reduces stress inside cells that can interfere with normal insulin signaling, which may allow insulin receptors in the liver and muscles to function more efficiently.
Why this rating: Human evidence is currently limited to a single small trial. The observed improvement in insulin sensitivity was meaningful, but the study lasted only four weeks and included just 20 participants. The proposed mechanism also did not fully manifest in human tissue samples. Because the finding has not been replicated in larger or longer studies, the evidence is considered promising but remains uncertain.
Cognitive Health Support: 4.0/10 (moderate evidence) —
TUDCA can cross into the brain and may help protect nerve cells from damage. It stabilizes mitochondria, reduces oxidative stress, and inhibits cellular pathways that trigger programmed cell death. Much of the research has focused on ALS, a disease characterized by the gradual loss of motor neurons that control muscle movement.
Why this rating: Early studies showed promise, but larger and more rigorous trials failed to replicate those benefits. Animal models continue to show neuroprotective effects, yet these results have not translated into meaningful clinical improvements in human ALS patients. Because the strongest clinical trials produced negative results, overall confidence in TUDCA as an ALS therapy remains low.
Eye Health: 3.0/10 (moderate evidence) —
TUDCA appears to help protect the retinal cells responsible for vision. In animal studies, it reduces oxidative stress and prevents cell death in key retinal cells. It also supports a cellular cleanup process that removes damaged components and helps maintain normal visual function.
Why this rating: Preclinical evidence is strong and consistent across multiple retinal disease models. However, no human trials have been published to date, and many animal studies used doses that may not be practical in humans. Until clinical data become available, confidence in real-world effectiveness remains low despite the encouraging early findings.

Dosage & Timeline

Standard Dosages

General Liver/Digestive Support: 250–500 mg/day
Liver Disease (clinical setting): 750 mg/day
Insulin Sensitivity: 1,750 mg/day
Neuroprotection (ALS trials): 2,000 mg/day

Timeline to See Results

Digestive/Bile Flow Improvement: 1 to 2 weeks
Liver Enzyme Reduction: 1 to 3 months, with most clinical trials measuring at 6 months
Insulin Sensitivity: Improvements observed at 4 weeks in the only available trial

All other outcomes (neuroprotection, eye health, cholesterol) lack sufficient human studies to establish an effectiveness timeline.

Safety Information

Gastrointestinal side effects: TUDCA is generally well tolerated, though some users experience mild digestive symptoms such as diarrhea, nausea, gas, or abdominal discomfort.
Bile duct obstruction: Those with complete bile duct obstruction should avoid TUDCA, as it increases bile flow and may worsen the condition.
Pregnancy and breastfeeding: Safety data for TUDCA during pregnancy or breastfeeding is insufficient. Anyone who is pregnant or nursing should consult a healthcare provider before use.
Medication interactions: TUDCA may interact with cholestyramine, colestipol, and colesevelam, which can reduce its absorption. It may also interact with insulin or insulin-sensitizing medications due to potential effects on insulin signaling.
Long-term safety: Clinical data supporting continuous use beyond approximately 18 months is limited. High-dose use of the related bile acid UDCA has caused harm in patients with certain liver conditions, raising theoretical concerns about prolonged high-dose bile acid supplementation.
Product quality: The FDA has warned that some bulk TUDCA products imported from China may be misbranded or lack adequate quality controls. Purchasing from reputable manufacturers is recommended.

Side Effects

Common side effects:

Mild gastrointestinal issues such as diarrhea, nausea, bloating, cramping, or abdominal discomfort (diarrhea is the most commonly reported)

Digestive upset is more likely when starting at higher doses or taking on an empty stomach

Rare side effects:

Constipation
Mild skin rash or itching
Dizziness
Hair loss has been reported with the related compound UDCA but is not well established for TUDCA

Most side effects are mild and temporary and often diminish as the body adjusts. Starting with a lower dose and taking TUDCA with food may help improve tolerance.

Usage Information

TUDCA is designed to support liver function and bile flow, protect cells from stress-related damage, aid in fat digestion and nutrient absorption, and provide neuroprotective benefits.

User Experience

Users most commonly report two benefits: reduced bloating and improved digestion, often within days to weeks, and a subjective sense of improved liver function. This is particularly common among people taking TUDCA alongside medications or supplements that place stress on the liver. TUDCA is especially popular in the bodybuilding and fitness community, where it is widely used for liver protection during oral steroid or prohormone cycles. This is likely its largest use case by volume.

People taking it for fatty liver or elevated liver enzymes frequently report improvements in bloodwork. One anecdotal report from a Parkinson's patient described taking 1,000 mg daily alongside other supplements and perceiving a slowing of disease progression, though this remains anecdotal and should be interpreted with caution.

Alternative Names

Tauroursodeoxycholic Acid

TUDCA